TNF blocker a second major application for Apollo Life Sciences' Oradel platform, currently in development for oral insulin. [ + ]

Stem Cell Sciences (SCS) has licensed the use of its novel mouse neural stem cell technology to Merck & Co for research use. [ + ]

Brisbane biotech company BioChip Innovations has become the first Australian company to sign a research collaboration agreement with Singapore’s Institute of Microelectronics (IME).

Leading and emerging scientists, engineers and innovators are being asked to nominate for Victoria's most prestigious science award. [ + ]

Resistance to glucocorticoid therapy remains an important factor in the battle to achieve high cure rates in childhood leukaemia. Researcher Richard Lock has helped develop a xenograph model to identify drug resistance mechanisms. [ + ]

An exhibition celebrating the work of the great naturalist Carl Linnaeus has opened in Sydney. [ + ]

Researchers have constructed a protein out of amino acids not found in natural proteins, discovering that they can form a complex, stable structure closely resembling a natural protein. Their findings could help scientists design drugs that look and act like real proteins but won't be degraded by enzymes or targeted by the immune system, as natural proteins are.

Angiogenesis inhibition is not enough - blocking the formation of new lymphatic vessels is vital to preventing secondary tumours. [ + ]

Minister for State Development John Mickel has congratulated Brisbane-based company BSD Robotics for its success at the Australian Innovation Shootout in New York as part of G’Day USA Australia Week.

Ruth Ganss is an immunologist by trade who has become intrigued by the nature of tumour development. [ + ]

Healthy and viable mice that survive until adulthood have been cloned from adult stem cells by scientists from Rockefeller University using cells called keratinocyte stem cells.

Sixty years ago this month, Australia developed a system of ensuring laboratory competence that has now been adopted by more than 70 countries.

Is there a link between a common heart defect and a high incidence of migraine? International experience seems to suggest so. [ + ]

NSW is running its annual BioFirst commercialisation awards again, offering cash and advice for local biotechs. [ + ]

Pharma giant Roche announces plans to restructure R&D activities and increase staff and spending. [ + ]